JPMorgan Chase & Co. (NYSE: JPM)

JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset & Wealth Management.

Take a look at the 1-year chart of JP (NYSE: JPM) with the added notations:

1-year chart of JP (NYSE: JPM)

JPM has a key level of support at $105 (green). The stock looks like it may be making its way back down to that level again, and traders should be able to expect some sort of a bounce from there, if it does. However, if the $105 support level were to break, lower prices should follow.

Continue Reading »

Hologic, Inc. (NASDAQ: HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally.

Take a look at the 1-year chart of Hologic (NASDAQ: HOLX) below with my added notations:

1-year chart of Hologic (NASDAQ: HOLX)

HOLX had formed a key $40 level (green) of resistance for the few months leading up to June. However, the stock broke through that resistance last week, and now that HOLX is sitting back on the $40 support, a bounce could be expected.

Continue Reading »

Redfin Corp (NASDAQ: RDFN)

Redfin Corporation operates as a real estate brokerage company in the United States. The company operates an online real estate marketplace and provides real estate services, such as assisting individuals to purchase or sell their residential property.

Take a look at the 1-year chart of Redfin (NASDAQ: RDFN) below with my added notations:

1-year chart of Redfin (NASDAQ: RDFN)

RDFN had consistently been hitting the $24 level (blue) as resistance for the past four months, which is a level that has also provided support. However, the stock broke through that resistance last week. Now that RDFN is sitting back on the $24 support, a bounce should be expected.

Continue Reading »

Aimmune Therapeutics (NASDAQ: AIMT)

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies.

Take a look at the 1-year chart of Aimmune (NASDAQ: AIMT) with the added notations:

AIMT has a key level of support at $28 (green).  The stock looks like its making its way back down to that level again, and traders should be able to expect some sort of a bounce from there. However, if the $28 support level were to break, lower prices should follow.

Continue Reading »

Agnico Eagle Mines Ltd (NYSE: AEM)

Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland. The company operates through Northern Business and Southern Business segments.

Take a look at the 1-year chart of Agnico Eagle Mines Limited (NYSE: AEM) below with my added notations:

1-year chart of Agnico Eagle Mines Limited (NYSE: AEM)

During the past four months, AEM has formed a clear level of resistance to watch at the $46 (red) mark. The stock has tested that mark multiple times since mid-February. A solid close above that $46 level would most likely lead to higher prices for AEM.

Continue Reading »